About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,979 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,979 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6261-6280 of 18,979 trials

RecruitingA Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSCThe study is designed to assess the safety and efficacy of LB-P8 in patients with primary sclerosing cholangitis.NCT06699121·Sacramento, California and 6 others CompletedExtension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative DiseaseThe purpose of this study is to evaluate the long-term safety and tolerability of pimavanserin in adult and elderly subjects with neuropsychiatric symptoms related to…NCT03623321·Gilbert, Arizona and 87 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

CompletedApixaban for the Prevention of Stroke in Subjects With Atrial FibrillationThe trial seeks to determine if apixaban, an investigational anticoagulant (blood-thinner) is as effective as standard therapy (warfarin) in preventing stroke and systemic…NCT00412984·Birmingham, Alabama and 1110 others

CompletedA Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesThe purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.NCT04255433·Birmingham, Alabama and 634 others

CompletedStudy Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's DisorderThe goal of the current trial is to determine efficacy and safety of Once-daily aripiprazole in reducing Total Tic Severity in children and adolescents with Tourette's Disorder.NCT01727700·Dothan, Alabama and 74 others

CompletedUse of Dabigatran Etexilate to Prevent Stroke and ThromboembolismThe purpose of this study is to evaluate major adverse bleeding risks, and thromboembolic event rates post radiofrequency (RF) ablation.NCT01976507·Nashville, Tennessee

CompletedSerum Markers of Ischemia Reperfusion Injury in Liver Transplant PatientsThis is an observational study examining serum markers in patients who are undergoing either a cadaveric liver transplant or a living related liver transplant.NCT00698399·Nashville, Tennessee

Enrolling by invitationLong-term Safety and Tolerability of BHV-7000A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsyNCT06443463·Birmingham, Alabama and 282 others

CompletedAn Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in AdultsThe purpose of this study is to evaluate the long-term safety of anifrolumab (MEDI-546) in adults with moderate to severe active systemic lupus erythematosus (SLE).NCT01753193·Birmingham, Alabama and 56 others

Completed16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis PatientsThe purpose of this study was to generate 16-week efficacy data, as well as up to 3-year efficacy, safety and tolerability data in subjects with active AS despite current or…NCT02008916·Mobile, Alabama and 56 others

CompletedVismodegib in Treating Patients With Recurrent or Refractory MedulloblastomaThis phase II trial is studying how well vismodegib works in treating adult patients with recurrent or refractory medulloblastoma.NCT00939484·Los Angeles, California and 12 others

RecruitingRESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory MyopathyRESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory…NCT06154252·Orange, California and 34 others

CompletedSafety and Immunogenicity Study of QIVc in Healthy Pediatric SubjectsThis phase 3 clinical study is a randomized, observer-blind, comparator-controlled, multicenter study of QIVc versus a US-licensed comparator QIV in children 6 months through 47…NCT04074928·Mobile, Alabama and 46 others

TerminatedAntihypertensive Treatment of Acute Cerebral Hemorrhage-IIThe specific aims of this study are to: 1.NCT01176565·Birmingham, Alabama and 170 others

RecruitingA Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI TrialThe COPE-AKI study is a randomized, pragmatic, parallel-arm trial comparing a multimodal intervention to usual care on hospital-free days through 90 days of study follow up.NCT05805709·Birmingham, Alabama and 8 others

WithdrawnA Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic RegimenThis is a multi-center, randomized, study to compare Iodine I 131 Tositumomab therapeutic regimen to Ibritumomab Tiuxetan therapeutic regimen in the treatment of patients with…NCT00319332·Iowa City, Iowa and 7 others

Active not recruitingPalbociclib After CDK and Endocrine Therapy (PACE)This research study is studying three combinations of drugs as treatments for breast cancer.NCT03147287·Miami, Florida and 21 others

CompletedThe Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using AbataceptThis investigator-initiated study will serve as a sub-study for the American College of Rheumatology-sponsored VERVE protocol currently funded by the NIH.NCT03604406·Boise, Idaho and 4 others

CompletedA Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered EsketamineThe purpose of this study is to evaluate the pharmacokinetics of a single dose of intranasally administered esketamine in participants with impaired renal function when compared…NCT02606084·Miami, Florida and 1 other

CompletedRollover Study Of Lapatinib In Cancer PatientsThe EGF19060 study is a rollover study to evaluate the long term safety of lapatinib and to provide lapatinib to patients who had a positive response in previous lapatinib studies…NCT00169533·Indianapolis, Indiana and 11 others

PreviousPage 314 of 949Next

Diabetes

in Tennessee

Heart Diseasein Tennessee